Is Nuvation Bio (NYSE:NUVB) Using Too Much Debt?

Simply Wall StNov 21 23:58

Nuvation Bio's Q3 2024 Highlights and Future Prospects

TipRanksNov 21 11:53

Nuvation Bio to Present at the Jefferies London Healthcare Conference

BusinesswireNov 13 05:05

Top 4 Health Care Stocks That May Plunge This Quarter

BenzingaNov 11 19:18

Nuvation Bio Is Maintained at Outperform by RBC Capital

Dow JonesNov 8 01:27 · Ratings

RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Raises Target Price to $6

Futu NewsNov 7 20:31 · Ratings